Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

R. Damhuis, S. Senan, A. Khakwani, S. Harden, A. Helland, T-E. Strand

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	ii27-ii28
Journal	Annals of Oncology
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz064.005 https://doi.org/10.1093/annonc/mdz064.005
Publication status	Published - Apr 2019

Access to Document

@article{48289dcaa8db41d08e1a16cd4d9caaa8,

title = "Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries",

author = "R. Damhuis and S. Senan and A. Khakwani and S. Harden and A. Helland and T-E. Strand",

year = "2019",

month = apr,

doi = "https://doi.org/10.1093/annonc/mdz064.005",

language = "English",

volume = "30",

pages = "ii27--ii28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

AU - Damhuis, R.

AU - Senan, S.

AU - Khakwani, A.

AU - Harden, S.

AU - Helland, A.

AU - Strand, T-E.

PY - 2019/4

Y1 - 2019/4

U2 - https://doi.org/10.1093/annonc/mdz064.005

DO - https://doi.org/10.1093/annonc/mdz064.005

M3 - Meeting Abstract

C2 - 32131201

SN - 0923-7534

VL - 30

SP - ii27-ii28

JO - Annals of Oncology

JF - Annals of Oncology

ER -